Loading...
OTCM
ZRSEF
Market cap353mUSD
Mar 13, Last price  
16.22USD
Name

Zur Rose Group AG

Chart & Performance

D1W1MN
OTCM:ZRSEF chart
No data to show
P/E
—
P/S
0.16
EPS
—
Div Yield, %
—
Shrs. gr., 5y
6.34%
Rev. gr., 5y
-5.58%
Revenues
1.02b
+4.91%
488,269,000487,192,000523,306,000910,609,000915,554,000834,418,000879,535,000982,921,0001,207,108,0001,355,539,0001,476,930,0001,726,503,0001,608,222,000969,462,0001,017,045,000
Net income
-97m
L
3,921,0008,674,0006,156,000-15,464,0007,154,0003,445,000-12,769,000-36,238,000-38,971,000-52,358,000-135,695,000-225,735,000-171,115,00082,280,000-97,253,000
CFO
-27m
L-69.57%
13,960,0002,806,00020,809,0002,004,0007,200,00018,872,000-13,830,000-22,227,000-33,227,000-82,571,000-67,511,000-130,631,000-97,287,000-87,415,000-26,598,000
Earnings
Aug 18, 2025

Profile

DocMorris AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. The company offers prescription and over-the-counter medicines, consumer health products, beauty and personal care products, nutritional supplements, painkillers, and first aid products, as well as medicines management services. It also operates stationary pharmacy shops. The company sells its products directly to physicians, online mail-order pharmacies, and private individuals under the Zur Rose, PromoFarma, TeleClinic, and DocMorris brands. The company was formerly known as Zur Rose Group AG and changed its name to DocMorris AG in May 2023. DocMorris AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.
URL
https://www.zurrosegroup.com/
IPO date
Jul 06, 2017
Employees
2,283
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,017,045
4.91%
969,462
-39.72%
1,608,222
-6.85%
Cost of revenue
958,977
888,214
1,527,984
Unusual Expense (Income)
NOPBT
58,068
81,248
80,238
NOPBT Margin
5.71%
8.38%
4.99%
Operating Taxes
(5,505)
(1,091)
1,246
Tax Rate
1.55%
NOPAT
63,573
82,339
78,992
Net income
(97,253)
-218.20%
82,280
-148.08%
(171,115)
-24.20%
Dividends
Dividend yield
Proceeds from repurchase of equity
31
42,055
BB yield
0.00%
-15.27%
Debt
Debt current
4,259
94,543
35,507
Long-term debt
334,341
264,980
531,333
Deferred revenue
Other long-term liabilities
9,032
12,353
7,323
Net debt
243,229
303,886
439,107
Cash flow
Cash from operating activities
(26,598)
(87,415)
(97,287)
CAPEX
(1,361)
(4,988)
(59,289)
Cash from investing activities
93,879
219,819
(89,771)
Cash from financing activities
(26,005)
(202,627)
39,107
FCF
173,877
30,220
102,147
Balance
Cash
95,371
104,028
156,402
Long term investments
(48,391)
(28,669)
Excess cash
44,519
7,164
47,322
Stockholders' equity
(151,878)
489,170
411,449
Invested Capital
813,232
766,151
829,792
ROIC
8.05%
10.32%
9.40%
ROCE
8.72%
10.41%
9.08%
EV
Common stock shares outstanding
11,781
11,674
10,775
Price
19.98
-72.91%
73.75
188.54%
25.56
-89.15%
Market cap
235,379
-72.66%
860,932
212.59%
275,415
-87.88%
EV
478,608
1,164,818
714,522
EBITDA
103,647
124,684
142,868
EV/EBITDA
4.62
9.34
5.00
Interest
19,541
19,138
17,726
Interest/NOPBT
33.65%
23.56%
22.09%